Company / EPS (Diluted)
Inogen Inc EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$4.42
FY2025
5-year range
-$4.42 / $0.94
FY2021-FY2025
Trend
-20.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
EPS (Diluted) has declined for 5 consecutive years, from $2.30 in FY2020 to $-4.42 in FY2025.
Based on SEC 10-K filings.
-4.42 in FY2025.
Declined from $-0.28 to $-4.42 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Inogen Inc's eps (diluted) has declined for 5 consecutive years.
- In FY2025, eps (diluted) decreased 20.4% year-over-year.
- Peak eps (diluted) was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.42 | -20.4% |
| FY2024 | -$3.67 | -1210.7% |
| FY2023 | -$0.28 | -3.7% |
| FY2022 | -$0.27 | -128.7% |
| FY2021 | $0.94 | -59.1% |
| FY2020 | $2.30 | +139.6% |
| FY2019 | $0.96 | -1.0% |
| FY2018 | $0.97 | +73.2% |
| FY2017 | $0.56 | +86.7% |
| FY2016 | $0.30 | -55.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026